A detailed history of Squarepoint Ops LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 106,591 shares of ANNX stock, worth $557,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares
106,591
Previous 21,500 395.77%
Holding current value
$557,470
Previous $105,000 500.95%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.49 - $7.2 $351,360 - $563,428
78,254 Added 276.15%
106,591 $631,000
Q2 2024

Aug 14, 2024

BUY
$4.33 - $6.79 $122,699 - $192,408
28,337 New
28,337 $138,000
Q1 2023

May 15, 2023

BUY
$3.74 - $7.46 $300,696 - $599,784
80,400 New
80,400 $309,000
Q2 2022

Aug 15, 2022

SELL
$2.11 - $4.06 $72,759 - $140,000
-34,483 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$2.73 - $11.94 $62,871 - $274,978
23,030 Added 201.08%
34,483 $94,000
Q4 2021

Feb 14, 2022

BUY
$11.49 - $22.0 $131,594 - $251,966
11,453 New
11,453 $132,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $249M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.